文献速递脊柱关节炎

新发银屑病中预测银屑病关节炎:多变量预测模型的开发

Predicting psoriatic arthritis in new-onset psoriasis: development of multivariable prediction models from an inception cohort study.
PubMed 文献 · Lancet Rheumatol · 2026-06-30

基于斯德哥尔摩银屑病起始队列628例新发银屑病患者,开发并内部验证两套预测模型:一套用于筛选适合转诊风湿科的患者,另一套用于识别亚临床银屑病关节炎高风险者。

要点

  • 关节痛、HLA-B27和全身炎症是未来银屑病关节炎最强预测因素。
  • 递归分割模型将患者分为4组,银屑病关节炎风险从1%到62%。
  • 模型对转诊和监测决策有净获益,但对预防治疗决策价值有限。

核心结论

  • 银屑病关节炎的预测因素在银屑病发病时即已存在。
  • 所开发模型可支持临床决策,但实施前需外部验证。

研究设计与样本

  • 入组时采集预测因素,开发两套转诊模型(含和不含生物标志物)及两套亚临床银屑病关节炎模型(3年和15年时间跨度)。
  • 采用递归分割和惩罚回归建模,通过区分度、校准度和临床合理风险阈值范围内的净获益评估模型。

主要发现

  • 递归分割结合实验室生物标志物,使用5个因素(关节痛、疲劳、银屑病表型、高敏C反应蛋白、银屑病疾病活动度)将患者分为4组,伴发银屑病关节炎风险从1%到62%。
  • 模型校准度合理,基于临床医生调查得出的阈值,对转诊和监测决策有正净获益,但对预防治疗决策价值有限。
  • 所有模型均表现出不稳定性,尤其是预后模型;疼痛、HLA-B27和全身炎症是未来银屑病关节炎最强预测因素。

关键数值与推荐

  • 递归分割模型使用5个因素(关节痛、疲劳、银屑病表型、高敏C反应蛋白、银屑病疾病活动度)分层,伴发银屑病关节炎风险范围1%-62%。
  • 15年时间跨度惩罚回归模型包含9个变量,3年时间跨度模型为其子集。

临床怎么用

  • 模型可辅助识别新发银屑病中适合转诊风湿科的患者以及亚临床银屑病关节炎高风险者。
  • 模型对转诊和监测决策有净获益,但不建议用于预防治疗决策。
  • 实施前需进行外部验证。

局限性

  • 所有模型均表现出不稳定性,尤其是预后模型。
  • 模型需外部验证后方可实施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psoriatic arthritis is underdiagnosed in people with psoriasis. Delayed psoriatic arthritis diagnosis is associated with worse outcomes, whereas early intervention improves prognosis. Therefore, we aimed to develop and internally validate two sets of prediction models. The first set intended to identify participants with new-onset psoriasis suitable for rheumatologist referral; the second set intended to identify participants with subclinical psoriatic arthritis at high risk of developing clinical psoriatic arthritis. We also aimed to identify psoriatic arthritis predictors. METHODS: We analysed data from the Stockholm Psoriasis Cohort, a Swedish psoriasis inception cohort that enrolled participants with psoriasis within 1 year of their first psoriasis lesion on non-hairy skin between Jan 5, 2001, and Dec 14, 2005. Predictors were obtained at enrolment. We developed two referral models (one with biomarkers and one without) and two models for subclinical psoriatic arthritis (one with a 3-year horizon and one with a 15-year horizon). We used recursive partitioning and penalised regression for prediction modelling and assessed the models using discrimination, calibration, and net benefit over a range of clinically reasonable risk thresholds informed by a clinician survey. People with lived experience of psoriasis were involved in study design. FINDINGS: Of 628 participants who reported no psoriatic arthritis at enrolment (347 [55%] females, 281 [45%] males, median age 40·9 years [IQR 30·1-56·0]), 83 (13%) had concomitant psoriatic arthritis. Recursive partitioning with laboratory biomarkers stratified participants into four groups using five factors (arthralgia, fatigue, psoriasis phenotype, high-sensitivity C-reactive protein, and psoriasis disease activity) with risks of concomitant psoriatic arthritis from 1% to 62%. The penalised regression model with a 15-year horizon included nine variables and the model with 3-year horizon a subset of these. All models showed good discrimination (optimism-adjusted area under the curve: 0·76-0·84). The models showed reasonable calibration and, based on thresholds derived from a clinician survey, positive net benefit for decisions on referral and monitoring, they but appeared to be of limited value for decisions about preventive treatment. All models, but most notably the prognostic models, exhibited instability. Pain, HLA-B27, and systemic inflammation were the strongest predictors for future psoriatic arthritis. INTERPRETATION: Predictors of psoriatic arthritis are already present at psoriasis onset. The models developed here could support clinical decision making, but they require external validation before implementation. FUNDING: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, Hudfonden, the National Psoriasis Foundation Psoriasisförbundet, the Stockholm County Council, and the Swedish Medical Research Council.

来源:Lancet Rheumatol,查看原文。版权归原作者所有。

引用

  1. Svedbom A, Mallbris L, Zabotti A, et al. Predicting psoriatic arthritis in new-onset psoriasis: development of multivariable prediction models from an inception cohort study. Lancet Rheumatol. 2026. PMID: 42379214. doi:10.1016/S2665-9913(26)00115-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。